​PhD student Eman Elayeh, together with members of our research group and international collaborators, has published a new review article in Lung Cancer: Targets and Therapy titled “Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC.”

The article highlights how integrating genomics, proteomics, and metabolomics can improve prediction of patient response to cancer immunotherapy and support more personalized treatment strategies in non-small cell lung cancer.

Published online in December 2025, this work reflects the research group’s continued commitment to biomarker discovery and precision oncology.​